Zemplar and dyspnoea 
Zemplar and dyspnoea Patient Reports February 10, 2012
Zemplar Side Effects Report #5773973-2
Zemplar side effect was reported by a Health Professional from UNITED STATES on June 06, 2008. Female patient, weighting 81.07 lb, was diagnosed with vitamin d deficiency and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, lip swelling. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, PHOSPHORUS BINDERS. Patient recovered.Zemplar Side Effects Report #5708490-9
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 11, 2008. Male patient, 83 years of age, was diagnosed with renal failure chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma
, c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5730681-1
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 29, 2008. Male patient, 83 years of age, was diagnosed with renal failure chronic, pain
, atrial fibrillation , nephrogenic anaemia, constipation prophylaxis, metabolic acidosis, angina pectoris and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma , c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML ONE DOSE, 1ML. During the same period patient was treated with PARACETAMOL, DIGOXIN, EPOETIN ALFA, FUROSEMIDE, LACTULOSE, BICARBONATE, GLYCERYL TRINITRATE, PARENTROVITE. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5736763-2
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on May 08, 2008. Male patient, 83 years of age, was diagnosed with renal failure chronic, pain
, atrial fibrillation , nephrogenic anaemia, constipation prophylaxis, metabolic acidosis, angina pectoris and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma , c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML ONE DOSE, 1ML. During the same period patient was treated with ACETAMINOPHEN, DIGOXIN, EPOETIN ALFA, FUROSEMIDE, LACTULOSE, BICARBONATE, GLYCERYL TRINITRATE, PARENTROVITE. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5239887-1
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Feb 08, 2007. Female patient, weighting 147.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, thrombosis prophylaxis, hyperphosphataemia, depression
, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: breast discomfort, breast disorder, dyspnoea, hydrothorax, lymphadenopathy, skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, TICLOPIDINE HYDROCHLORIDE, MIMPARA, SEVELAMER HYDROCHLORIDE, TIANEPTINE, ENOXAPARIN, EPOETIN ALFA. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5248052-3
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Feb 21, 2007. Female patient, weighting 147.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, thrombosis prophylaxis, hyperphosphataemia, depression
, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: breast discomfort, breast disorder, dyspnoea, hydrothorax, lymphadenopathy, skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, TICLOPIDINE HYDROCHLORIDE, MIMPARA, SEVELAMER HYDROCHLORIDE, TIANEPTINE, ENOXAPARIN, EPOETIN ALFA. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5272246-4
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Mar 13, 2007. Female patient, weighting 147.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, thrombosis prophylaxis, hyperphosphataemia, depression
, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: breast discomfort, breast disorder, dyspnoea, hydrothorax, lymphadenopathy, skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, TICLOPIDINE HYDROCHLORIDE, MIMPARA, SEVELAMER HYDROCHLORIDE, TIANEPTINE, ENOXAPARIN, EPOETIN ALFA. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5282014-5
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Mar 22, 2007. Female patient, weighting 147.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, thrombosis prophylaxis, hyperphosphataemia, depression
, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: breast discomfort, breast disorder, dyspnoea, hydrothorax, lymphadenopathy, pleural effusion, skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, TICLOPIDINE HYDROCHLORIDE, MIMPARA, SEVELAMER HYDROCHLORIDE, TIANEPTINE, ENOXAPARIN, EPOETIN ALFA. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5351875-3
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on May 30, 2007. Female patient, weighting 147.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, thrombosis prophylaxis, hyperphosphataemia, depression
, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: breast cancer , breast discomfort, breast disorder, dyspnoea, hydrothorax, metastases to liver, metastases to lymph nodes, pleural effusion, skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, TICLOPIDINE HYDROCHLORIDE, MIMPARA, SEVELAMER HYDROCHLORIDE, TIANEPTINE, NADROPARIN CALCIUM, EPOETIN ALFA. Patient was hospitalized. Patient died on 05/28/2007.Zemplar Side Effects Report #5737593-8
Zemplar side effect was reported by a Health Professional from UNITED STATES on Mar 07, 2008. Female patient, weighting 194.0 lb, was diagnosed with renal failure chronic, hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, nausea
. Zemplar dosage: unknown. Patient recovered.Zemplar Side Effects Report #6032006-3
Zemplar side effect was reported by a Physician from ARGENTINA on Dec 30, 2008. Female patient, weighting 187.4 lb, was diagnosed with renal failure chronic, hypertension, cardiac disorder, dyslipidaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Zemplar dosage: unknown. During the same period patient was treated with ATENOLOL, ASPIRIN, SIMVASTATIN, TRIMETAZIDINE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4593074-9
Zemplar side effect was reported by a Consumer or non-health professional from on July 15, 2004. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with renal failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood pressure increased, chest discomfort, cough, dyspnoea, tachycardia. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA. Patient recovered.
Zemplar Side Effects Report #6126623-X
Zemplar side effect was reported by a Consumer or non-health professional from on Mar 17, 2009. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute respiratory failure, communication disorder, cyanosis, dyspnoea, hypercalcaemia, hypercapnia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with RENAGEL, MIMPARA, ISCOVER, MIACALCIN, LEPUR, FILICINE, AMLOPEN. Patient was hospitalized. Patient died on 03/17/2009.
Zemplar Side Effects Report #6130209-0
Zemplar side effect was reported by a Consumer or non-health professional from on Mar 24, 2009. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute respiratory failure, communication disorder, cyanosis, dyspnoea, hypercalcaemia, hypercapnia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with RENAGEL, MIMPARA, ISCOVER, MIACALCIN, LEPUR, FILICINE, AMLOPEN. Patient was hospitalized. Patient died on 03/17/2009.
Zemplar Side Effects Report #5932484-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Oct 23, 2008. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer
, dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, FOLIC ACID, NEUROGRISEVIT, EVATON, BUFLOMEDIL HYDROCHLORIDE, SEVELAMER. Patient was hospitalized. Patient died on 07/31/2008.Zemplar Side Effects Report #5977781-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Nov 27, 2008. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer
, dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, FOLIC ACID, NEUROGRISEVIT, EVATON, BUFLOMEDIL HYDROCHLORIDE, SEVELAMER. Patient was hospitalized. Patient died on 07/31/2008.Zemplar Side Effects Report #5979911-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 05, 2008. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer
, dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, FOLIC ACID, NEUROGRISEVIT, EVATON, BUFLOMEDIL HYDROCHLORIDE, SEVELAMER. Patient was hospitalized. Patient died on 07/31/2008.Zemplar Side Effects Report #6110944-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Mar 04, 2009. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer
, cardio-respiratory arrest, dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, COSMOFER, SUPERAMIN, FILICINE, NEUROBION, EVATON, LOFTYL, RENAGEL. Patient was hospitalized. Patient died on 07/31/2008.Zemplar Side Effects Report #6071924-7
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 05, 2009. Female patient, 80 years of age, weighting 136.7 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, renal failure chronic, atrial fibrillation
and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, dyspnoea, pleural effusion. Zemplar dosage: unknown. During the same period patient was treated with VENOFER, INTELLECTA, FILICINE, SINTROM, ALUCAP. Patient was hospitalized. Patient died on 12/04/2008.Zemplar Side Effects Report #5089354-3
Zemplar side effect was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain
, dyspnoea. Zemplar dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.Zemplar Side Effects Report #5143689-4
Zemplar side effect was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain
, abdominal pain upper, acute pulmonary oedema, dyspnoea, fluid overload. Zemplar dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.Zemplar Side Effects Report #5150058-X
Zemplar side effect was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain
, acute pulmonary oedema, dyspnoea, fluid overload. Zemplar dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.Zemplar Side Effects Report #5150127-4
Zemplar side effect was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain
, acute pulmonary oedema, dyspnoea, fluid overload. Zemplar dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.Zemplar Side Effects Report #5151661-3
Zemplar side effect was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain
, acute pulmonary oedema, dyspnoea, fluid overload. Zemplar dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.Zemplar Side Effects Report #5153070-X
Zemplar side effect was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain
, acute pulmonary oedema, dyspnoea, fluid overload. Zemplar dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.Zemplar Side Effects Report #5153579-9
Zemplar side effect was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain
, acute pulmonary oedema, dyspnoea, fluid overload. Zemplar dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.Zemplar Side Effects Report #5570694-6
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 12, 2007. Male patient, 76 years of age, weighting 160.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with INTELECTA AMP, IRBESARTAN, DARBEPOETIN ALFA, SEVELAMER, TITRALAC, TAMSULOSIN, AMIODARONE HYDROCHLORIDE. Patient recovered.
Zemplar Side Effects Report #6045641-3
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 16, 2009. Male patient, 73 years of age, weighting 171.5 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, atrial fibrillation
, hyperphosphataemia, coronary artery disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, VENOFER, NEUROBION, SUPERAMINE, ANGORON, RENAGEL, DILATREND, MONOSORDIL. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5920410-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Oct 10, 2008. Female patient, 72 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, pericarditis. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER, LEVOCARNITINE, NEUROGRISEVIT, ENOXAPARIN, MIRCERA, IMDUR, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5576919-5
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Dec 21, 2007. Male patient, 70 years of age, was diagnosed with hyperparathyroidism secondary, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, dyspnoea, hypertension, impaired self-care, nausea
, pleural effusion. Zemplar dosage: unknown. During the same period patient was treated with NOVOLOG. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5694600-9
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Mar 26, 2008. Male patient, 70 years of age, was diagnosed with hyperparathyroidism secondary, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, dyspnoea, hypertension, impaired self-care, nausea
, pleural effusion. Zemplar dosage: 5 MCG/ML, 1 ML. During the same period patient was treated with NOVOLOG. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5694759-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 04, 2008. Male patient, 70 years of age, was diagnosed with hyperparathyroidism secondary, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, dyspnoea, hypertension, impaired self-care, nausea
, pleural effusion. Zemplar dosage: 5 MCG/ML, 1 ML. During the same period patient was treated with NOVOLOG. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #6086171-2
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 18, 2009. Male patient, 70 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease
, renal failure chronic, hyperphosphataemia, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , dyspnoea, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with DILATREND, FILICINE, FORSENOL, RENAGEL, HEPARIN LEO, NEORECORMON, VENOFER. Patient died on 02/17/2009.Zemplar Side Effects Report #6053268-2
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 20, 2009. Female patient, 50 years of age, weighting 194.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, FERROVIN, SUPERAMIN, NEUROBION, RENAGEL, CALCIORAL, DILTIAZEM, ATORSTAT. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #6070908-2
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 02, 2009. Female patient, 50 years of age, weighting 194.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, FERROVIN, SUPERAMIN, NEUROBION, RENAGEL, CALCIORAL, DILTIAZEM, ATORSTAT. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #6102458-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 25, 2009. Female patient, 50 years of age, weighting 194.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, FERROVIN, SUPERAMIN, NEUROBION, RENAGEL, CALCIORAL, TILDIEM, ATORSTAT. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5200141-5
Zemplar side effect was reported by a Physician from GERMANY on Dec 28, 2006. Male patient, weighting 207.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina pectoris, cardiac failure congestive, dyspnoea, electrocardiogram change, nausea
, oedema peripheral, pleuritic pain, productive cough. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5234695-X
Zemplar side effect was reported by a Physician from GERMANY on Feb 01, 2007. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, oedema peripheral. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5236382-0
Zemplar side effect was reported by a Physician from GERMANY on Feb 03, 2007. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, oedema peripheral, pleural effusion. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5243125-3
Zemplar side effect was reported by a Physician from GERMANY on Feb 12, 2007. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, oedema peripheral. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5248364-3
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Feb 19, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina pectoris, dyspnoea. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5273082-5
Zemplar side effect was reported by a Physician from VENEZUELA on Mar 14, 2007. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, cardiac failure, hypertension, vitamin supplementation, anaemia, blood phosphorus increased, gastrooesophageal reflux disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: discomfort, dyspnoea, lower respiratory tract infection, respiratory disorder, retinal operation, septic shock. Zemplar dosage: unknown. During the same period patient was treated with CARVEDILOL, AMLODIPINE, BENUTREX, FOLIC ACID, EPOGEN, CALCIUM CARBONATE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5285137-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Mar 26, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease
, dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, renal failure chronic, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5289776-1
Zemplar side effect was reported by a Physician from VENEZUELA on Mar 29, 2007. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, cardiac failure, hypertension, vitamin supplementation, anaemia, blood phosphorus increased, gastrooesophageal reflux disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: discomfort, dyspnoea, lower respiratory tract infection, respiratory disorder, retinal operation, septic shock. Zemplar dosage: unknown. During the same period patient was treated with CARVEDILOL, AMLODIPINE, BENUTREX, FOLIC ACID, EPOGEN, CALCIUM CARBONATE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/27/2007.
Zemplar Side Effects Report #5303778-8
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Apr 11, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease
, dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, renal failure chronic, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5321880-1
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Apr 30, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease
, dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5156549-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 13, 2006. Female patient, weighting 198.4 lb, was diagnosed with hyperparathyroidism secondary, cardiac failure, myocardial ischaemia, hypertension, bronchitis chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac failure, chest pain , dyspnoea, inflammation, intra-abdominal haemorrhage, oedema, pelvic mass, pulse absent. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, MOLSIDOMINE, AMINOPHYLLINE, WARFARIN, FRAXIAPRIN. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5168565-2
Zemplar side effect was reported by a Physician from GERMANY on Nov 28, 2006. Male patient, weighting 202.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea. Zemplar dosage: unknown. During the same period patient was treated with CYCLOSPORINE, CELLCEPT, RAMIPRIL ABZ, METOHEXAL, NITRENDIPINE, MOXONIDIN, TOREM. Patient recovered.
Zemplar Side Effects Report #5192327-3
Zemplar side effect was reported by a Physician from GERMANY on Dec 18, 2006. Male patient, weighting 207.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina pectoris, cardiac failure congestive, dyspnoea, electrocardiogram change. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5576929-8
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Dec 20, 2007. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dyspnoea, extrinsic vascular compression, pneumonia staphylococcal, staphylococcal infection
, traumatic haematoma, white blood cell count increased. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5588644-5
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Jan 02, 2008. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dyspnoea, extrinsic vascular compression, pneumonia staphylococcal, staphylococcal infection
, traumatic haematoma, white blood cell count increased. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #6020330-X
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 18, 2008. Male patient, weighting 174.8 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, atrial fibrillation
, hyperphosphataemia, coronary artery disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, VENOFER, NEUROBION, SUPERAMINE, ANGORON, RENAGEL, DILATREND, MONOSORDIL. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4860025-9
Zemplar side effect was reported by a Consumer or non-health professional from VENEZUELA on Dec 06, 2005. Female patient, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary, hypertension, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, pericardial effusion, pleural effusion. Zemplar dosage: unknown. During the same period patient was treated with IRBESARTAN, NIFEDIPINE, RILMENIDINE, BI PREDONIUM, VITAMIN. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #4974453-4
Zemplar side effect was reported by a Physician from SPAIN on Mar 28, 2006. Male patient, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac failure, congestive cardiomyopathy, dyspnoea, electrocardiogram st segment elevation, ischaemic cardiomyopathy, mitral valve incompetence, oedema peripheral, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, FOLIC ACID, TAMSULOSIN, VITAMINES, OMEPRAZOLE, EPOETIN ALFA, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5760103-6
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on May 26, 2008. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with hyperparathyroidism, prophylaxis, gout
, blood phosphorus increased, dialysis , hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac enzymes increased, chest pain , dyspnoea, impaired work ability. Zemplar dosage: 5MCG/ML. During the same period patient was treated with ALLOPURINOL, ACETAMINOPHEN, ATENOLOL, CALCIUM CARBONATE, EMLA BANDAGE, EMLA BANDAGE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5870793-5
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 26, 2008. Male patient, 63 years of age, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Zemplar dosage: 5 MCG/ML, 2 ML PER WEEK. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5910471-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Oct 02, 2008. Male patient, 63 years of age, weighting 125.0 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina pectoris, dyspnoea. Zemplar dosage: 5 MCG/ML, 2 ML PER WEEK. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #6074146-9
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Feb 04, 2009. Female patient, 58 years of age, weighting 97.00 lb, was diagnosed with hyperparathyroidism, hyperphosphataemia, hyperlipidaemia, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, pericardial effusion. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, FLUVASTATIN, EPOETIN BETA, SEVELAMER. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #6075578-5
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Feb 04, 2009. Female patient, 46 years of age, weighting 136.7 lb, was diagnosed with hyperparathyroidism, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, pericardial effusion. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, EPOETIN BETA, EPOETIN BETA, EPOETIN BETA. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #6098069-4
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Feb 19, 2009. Male patient, 22 years of age, weighting 143.3 lb, was diagnosed with hyperparathyroidism, gastritis erosive, vitamin supplementation, bronchitis
, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest pain , choking , dyspnoea, headache , hypertension, pulmonary oedema. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, FOLIC ACID, AZITHROMYCIN, URAPIDIL, CEFTRIAXON, AMLODIPINE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #6098970-1
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Feb 19, 2009. Male patient, 22 years of age, weighting 143.3 lb, was diagnosed with hyperparathyroidism, gastritis erosive, hypovitaminosis, prophylaxis, bronchitis
, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest pain , choking , dyspnoea, headache , hypertension, pulmonary oedema. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, FOLIC ACID, FOLIC ACID, AZITHROMYCIN, URAPIDIL, CEFTRIAXON. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5840981-2
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Aug 01, 2008. Male patient, weighting 138.9 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asphyxia, cough, dyspnoea, hypersensitivity, hypotension, oropharyngeal discomfort. Zemplar dosage: unknown. Patient recovered.
Zemplar Side Effects Report #6036006-9
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2009. Male patient, weighting 176.2 lb, was diagnosed with hyperparathyroidism, atrial fibrillation
and was treated with Zemplar. After drug was administered, patient experienced the following side effects: bradycardia, cardiac failure congestive, dyspnoea, renal failure chronic. Zemplar dosage: unknown. During the same period patient was treated with PHOSLO, COUMADIN, CLONIDINE, LANOXIN, FLOMAX, HYDRALAZINE, LIPITOR. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4749345-6
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on June 17, 2005. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism, blood phosphorus increased, gastric disorder, chronic obstructive pulmonary disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal discomfort, anorexia, colitis ischaemic, dyspnoea, infrequent bowel movements, malaise, sepsis
, urinary tract infection , urine output decreased. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, NADROPARIN, NITROGLYCERIN, NATRIUMBICARBONAT, DOMPERIDON, DUOVENT. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4754853-8
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on June 17, 2005. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism, blood phosphorus increased, gastric disorder, chronic obstructive pulmonary disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal discomfort, anorexia, colitis ischaemic, dyspnoea, gastroenteritis
, infrequent bowel movements, malaise, sepsis , urinary tract infection . Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, NADROPARIN, NITROGLYCERIN, NATRIUMBICARBONAT, DOMPERIDON, DUOVENT. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4838176-4
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on June 17, 2005. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism, blood phosphorus increased, gastric disorder, chronic obstructive pulmonary disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal discomfort, anorexia, colitis ischaemic, dyspnoea, enterocolitis infectious, gastroenteritis
, infrequent bowel movements, malaise, sepsis . Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, NADROPARIN, NITROGLYCERIN, NATRIUMBICARBONAT, DOMPERIDON, DUOVENT. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5692431-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Mar 28, 2008. Male patient, 83 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma
, c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5697979-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 03, 2008. Male patient, 83 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma
, c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5761354-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on May 29, 2008. Female patient, 62 years of age, was diagnosed with acidosis, gastrooesophageal reflux disease, constipation
and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atelectasis, chest discomfort, dyspnoea, ejection fraction abnormal, hypocalcaemia, myocardial infarction, pleural effusion, upper respiratory tract infection. Zemplar dosage: 5 MCG/ML. During the same period patient was treated with BICARBONATE, OMEPRAZOLE, LACTULOSE, HUMALOG PEN, LANTUS OPTISET, ALFACALCIDOL, TRIOBE, ORALVITE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4820480-7
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on Oct 27, 2005. Male patient was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, hypertension. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.